Annual Long Term Debt
$7.36 M
-$6.69 M-47.60%
December 31, 2023
Summary
- As of February 20, 2025, CUE annual long term debt is $7.36 million, with the most recent change of -$6.69 million (-47.60%) on December 31, 2023.
- During the last 3 years, CUE annual long term debt has risen by +$5.00 million (+210.87%).
- CUE annual long term debt is now -47.60% below its all-time high of $14.05 million, reached on December 31, 2022.
Performance
CUE Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$2.65 M
-$1.59 M-37.52%
September 30, 2024
Summary
- As of February 20, 2025, CUE quarterly long term debt is $2.65 million, with the most recent change of -$1.59 million (-37.52%) on September 30, 2024.
- Over the past year, CUE quarterly long term debt has dropped by -$1.59 million (-37.52%).
- CUE quarterly long term debt is now -84.08% below its all-time high of $16.67 million, reached on June 30, 2022.
Performance
CUE Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
CUE Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -47.6% | -37.5% |
3 y3 years | +210.9% | -81.1% |
5 y5 years | +100.0% | -81.1% |
CUE Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -47.6% | +43.8% | -84.1% | at low |
5 y | 5-year | -47.6% | +446.3% | -84.1% | -100.0% |
alltime | all time | -47.6% | -100.0% | -84.1% | -100.0% |
Cue Biopharma Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.65 M(-37.5%) |
Jun 2024 | - | $4.25 M(-27.0%) |
Mar 2024 | - | $5.82 M(-20.9%) |
Dec 2023 | $7.36 M(-47.6%) | $7.36 M(-18.3%) |
Sep 2023 | - | $9.02 M(-15.9%) |
Jun 2023 | - | $10.72 M(-13.7%) |
Mar 2023 | - | $12.41 M(-11.7%) |
Dec 2022 | $14.05 M(+174.4%) | $14.05 M(-8.2%) |
Sep 2022 | - | $15.31 M(-8.1%) |
Jun 2022 | - | $16.67 M(+14.0%) |
Mar 2022 | - | $14.62 M(+185.5%) |
Dec 2021 | $5.12 M | $5.12 M(>+9900.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $0.00(0.0%) |
Jun 2021 | - | $0.00(-100.0%) |
Mar 2021 | - | $1.08 M(-54.2%) |
Dec 2020 | $2.37 M(+75.7%) | $2.37 M(-34.8%) |
Sep 2020 | - | $3.63 M(-13.1%) |
Jun 2020 | - | $4.18 M(+2055.7%) |
Mar 2020 | - | $194.00 K(-85.6%) |
Dec 2019 | $1.35 M(>+9900.0%) | $1.35 M(-48.4%) |
Sep 2019 | - | $2.61 M(-31.1%) |
Jun 2019 | - | $3.79 M(-23.4%) |
Mar 2019 | - | $4.95 M(>+9900.0%) |
Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Cue Biopharma annual long term debt?
- What is the all time high annual long term debt for Cue Biopharma?
- What is Cue Biopharma annual long term debt year-on-year change?
- What is Cue Biopharma quarterly long term debt?
- What is the all time high quarterly long term debt for Cue Biopharma?
- What is Cue Biopharma quarterly long term debt year-on-year change?
What is Cue Biopharma annual long term debt?
The current annual long term debt of CUE is $7.36 M
What is the all time high annual long term debt for Cue Biopharma?
Cue Biopharma all-time high annual long term debt is $14.05 M
What is Cue Biopharma annual long term debt year-on-year change?
Over the past year, CUE annual long term debt has changed by -$6.69 M (-47.60%)
What is Cue Biopharma quarterly long term debt?
The current quarterly long term debt of CUE is $2.65 M
What is the all time high quarterly long term debt for Cue Biopharma?
Cue Biopharma all-time high quarterly long term debt is $16.67 M
What is Cue Biopharma quarterly long term debt year-on-year change?
Over the past year, CUE quarterly long term debt has changed by -$1.59 M (-37.52%)